Global Biopharmaceutical Cold Chain Transport Market Research Report 2024

Publication ID:

PB505251492

Publication Date:

May 10, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

Biopharmaceutical Logistics is the logistics of Biopharmaceutical, medical and surgical supplies, and other products needed to support doctors, nurses, and other health and dental care providers.
The global Biopharmaceutical Cold Chain Transport market was valued at US$ 13130 million in 2023 and is anticipated to reach US$ 20090 million by 2030, witnessing a CAGR of 6.3% during the forecast period 2024-2030.
The Biopharmaceutical Transport market is primarily driven by the rapid growth of the biopharmaceutical industry, which includes the production and distribution of biologic drugs, vaccines, and other complex biopharmaceutical products. These products often require specialized transportation and handling due to their sensitivity to temperature variations and the need for maintaining product integrity. The increasing demand for personalized medicine, cell therapies, and advanced treatments further fuels the need for reliable and efficient biopharmaceutical transport solutions. However, this market also faces challenges such as stringent regulatory requirements, complex logistics networks, and the need to maintain a consistent cold chain to ensure the stability and efficacy of biopharmaceutical products during transit. Innovations in temperature-controlled packaging, monitoring technologies, and streamlined logistics processes are crucial to addressing these challenges and ensuring the safe and timely delivery of biopharmaceuticals to patients worldwide.
This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical Cold Chain Transport, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical Cold Chain Transport.
Report Scope
The Biopharmaceutical Cold Chain Transport market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biopharmaceutical Cold Chain Transport market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biopharmaceutical Cold Chain Transport companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Deutsche Post DHL
Kuehne + Nagel
FedEx
AmerisourceBergen
UPS (Marken)
DB Schenker
XPO Logistics
Panalpina
Nippon Express
GEODIS
VersaCold
Agility
DSV
Sinotrans
Kerry Logistics
SF Express
CEVA
CH Robinson
Air Canada Cargo
Segment by Type
Ground Shipping
Sea Shipping
Air Shipping
Segment by Application
Blood Products
Vaccines
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biopharmaceutical Cold Chain Transport companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical Cold Chain Transport Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Ground Shipping
1.2.3 Sea Shipping
1.2.4 Air Shipping
1.3 Market by Application
1.3.1 Global Biopharmaceutical Cold Chain Transport Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Blood Products
1.3.3 Vaccines
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical Cold Chain Transport Market Perspective (2019-2030)
2.2 Biopharmaceutical Cold Chain Transport Growth Trends by Region
2.2.1 Global Biopharmaceutical Cold Chain Transport Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biopharmaceutical Cold Chain Transport Historic Market Size by Region (2019-2024)
2.2.3 Biopharmaceutical Cold Chain Transport Forecasted Market Size by Region (2025-2030)
2.3 Biopharmaceutical Cold Chain Transport Market Dynamics
2.3.1 Biopharmaceutical Cold Chain Transport Industry Trends
2.3.2 Biopharmaceutical Cold Chain Transport Market Drivers
2.3.3 Biopharmaceutical Cold Chain Transport Market Challenges
2.3.4 Biopharmaceutical Cold Chain Transport Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical Cold Chain Transport Players by Revenue
3.1.1 Global Top Biopharmaceutical Cold Chain Transport Players by Revenue (2019-2024)
3.1.2 Global Biopharmaceutical Cold Chain Transport Revenue Market Share by Players (2019-2024)
3.2 Global Biopharmaceutical Cold Chain Transport Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biopharmaceutical Cold Chain Transport Revenue
3.4 Global Biopharmaceutical Cold Chain Transport Market Concentration Ratio
3.4.1 Global Biopharmaceutical Cold Chain Transport Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Cold Chain Transport Revenue in 2023
3.5 Biopharmaceutical Cold Chain Transport Key Players Head office and Area Served
3.6 Key Players Biopharmaceutical Cold Chain Transport Product Solution and Service
3.7 Date of Enter into Biopharmaceutical Cold Chain Transport Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical Cold Chain Transport Breakdown Data by Type
4.1 Global Biopharmaceutical Cold Chain Transport Historic Market Size by Type (2019-2024)
4.2 Global Biopharmaceutical Cold Chain Transport Forecasted Market Size by Type (2025-2030)
5 Biopharmaceutical Cold Chain Transport Breakdown Data by Application
5.1 Global Biopharmaceutical Cold Chain Transport Historic Market Size by Application (2019-2024)
5.2 Global Biopharmaceutical Cold Chain Transport Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biopharmaceutical Cold Chain Transport Market Size (2019-2030)
6.2 North America Biopharmaceutical Cold Chain Transport Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biopharmaceutical Cold Chain Transport Market Size by Country (2019-2024)
6.4 North America Biopharmaceutical Cold Chain Transport Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biopharmaceutical Cold Chain Transport Market Size (2019-2030)
7.2 Europe Biopharmaceutical Cold Chain Transport Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biopharmaceutical Cold Chain Transport Market Size by Country (2019-2024)
7.4 Europe Biopharmaceutical Cold Chain Transport Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical Cold Chain Transport Market Size (2019-2030)
8.2 Asia-Pacific Biopharmaceutical Cold Chain Transport Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biopharmaceutical Cold Chain Transport Market Size by Region (2019-2024)
8.4 Asia-Pacific Biopharmaceutical Cold Chain Transport Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biopharmaceutical Cold Chain Transport Market Size (2019-2030)
9.2 Latin America Biopharmaceutical Cold Chain Transport Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biopharmaceutical Cold Chain Transport Market Size by Country (2019-2024)
9.4 Latin America Biopharmaceutical Cold Chain Transport Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical Cold Chain Transport Market Size (2019-2030)
10.2 Middle East & Africa Biopharmaceutical Cold Chain Transport Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biopharmaceutical Cold Chain Transport Market Size by Country (2019-2024)
10.4 Middle East & Africa Biopharmaceutical Cold Chain Transport Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Deutsche Post DHL
11.1.1 Deutsche Post DHL Company Detail
11.1.2 Deutsche Post DHL Business Overview
11.1.3 Deutsche Post DHL Biopharmaceutical Cold Chain Transport Introduction
11.1.4 Deutsche Post DHL Revenue in Biopharmaceutical Cold Chain Transport Business (2019-2024)
11.1.5 Deutsche Post DHL Recent Development
11.2 Kuehne + Nagel
11.2.1 Kuehne + Nagel Company Detail
11.2.2 Kuehne + Nagel Business Overview
11.2.3 Kuehne + Nagel Biopharmaceutical Cold Chain Transport Introduction
11.2.4 Kuehne + Nagel Revenue in Biopharmaceutical Cold Chain Transport Business (2019-2024)
11.2.5 Kuehne + Nagel Recent Development
11.3 FedEx
11.3.1 FedEx Company Detail
11.3.2 FedEx Business Overview
11.3.3 FedEx Biopharmaceutical Cold Chain Transport Introduction
11.3.4 FedEx Revenue in Biopharmaceutical Cold Chain Transport Business (2019-2024)
11.3.5 FedEx Recent Development
11.4 AmerisourceBergen
11.4.1 AmerisourceBergen Company Detail
11.4.2 AmerisourceBergen Business Overview
11.4.3 AmerisourceBergen Biopharmaceutical Cold Chain Transport Introduction
11.4.4 AmerisourceBergen Revenue in Biopharmaceutical Cold Chain Transport Business (2019-2024)
11.4.5 AmerisourceBergen Recent Development
11.5 UPS (Marken)
11.5.1 UPS (Marken) Company Detail
11.5.2 UPS (Marken) Business Overview
11.5.3 UPS (Marken) Biopharmaceutical Cold Chain Transport Introduction
11.5.4 UPS (Marken) Revenue in Biopharmaceutical Cold Chain Transport Business (2019-2024)
11.5.5 UPS (Marken) Recent Development
11.6 DB Schenker
11.6.1 DB Schenker Company Detail
11.6.2 DB Schenker Business Overview
11.6.3 DB Schenker Biopharmaceutical Cold Chain Transport Introduction
11.6.4 DB Schenker Revenue in Biopharmaceutical Cold Chain Transport Business (2019-2024)
11.6.5 DB Schenker Recent Development
11.7 XPO Logistics
11.7.1 XPO Logistics Company Detail
11.7.2 XPO Logistics Business Overview
11.7.3 XPO Logistics Biopharmaceutical Cold Chain Transport Introduction
11.7.4 XPO Logistics Revenue in Biopharmaceutical Cold Chain Transport Business (2019-2024)
11.7.5 XPO Logistics Recent Development
11.8 Panalpina
11.8.1 Panalpina Company Detail
11.8.2 Panalpina Business Overview
11.8.3 Panalpina Biopharmaceutical Cold Chain Transport Introduction
11.8.4 Panalpina Revenue in Biopharmaceutical Cold Chain Transport Business (2019-2024)
11.8.5 Panalpina Recent Development
11.9 Nippon Express
11.9.1 Nippon Express Company Detail
11.9.2 Nippon Express Business Overview
11.9.3 Nippon Express Biopharmaceutical Cold Chain Transport Introduction
11.9.4 Nippon Express Revenue in Biopharmaceutical Cold Chain Transport Business (2019-2024)
11.9.5 Nippon Express Recent Development
11.10 GEODIS
11.10.1 GEODIS Company Detail
11.10.2 GEODIS Business Overview
11.10.3 GEODIS Biopharmaceutical Cold Chain Transport Introduction
11.10.4 GEODIS Revenue in Biopharmaceutical Cold Chain Transport Business (2019-2024)
11.10.5 GEODIS Recent Development
11.11 VersaCold
11.11.1 VersaCold Company Detail
11.11.2 VersaCold Business Overview
11.11.3 VersaCold Biopharmaceutical Cold Chain Transport Introduction
11.11.4 VersaCold Revenue in Biopharmaceutical Cold Chain Transport Business (2019-2024)
11.11.5 VersaCold Recent Development
11.12 Agility
11.12.1 Agility Company Detail
11.12.2 Agility Business Overview
11.12.3 Agility Biopharmaceutical Cold Chain Transport Introduction
11.12.4 Agility Revenue in Biopharmaceutical Cold Chain Transport Business (2019-2024)
11.12.5 Agility Recent Development
11.13 DSV
11.13.1 DSV Company Detail
11.13.2 DSV Business Overview
11.13.3 DSV Biopharmaceutical Cold Chain Transport Introduction
11.13.4 DSV Revenue in Biopharmaceutical Cold Chain Transport Business (2019-2024)
11.13.5 DSV Recent Development
11.14 Sinotrans
11.14.1 Sinotrans Company Detail
11.14.2 Sinotrans Business Overview
11.14.3 Sinotrans Biopharmaceutical Cold Chain Transport Introduction
11.14.4 Sinotrans Revenue in Biopharmaceutical Cold Chain Transport Business (2019-2024)
11.14.5 Sinotrans Recent Development
11.15 Kerry Logistics
11.15.1 Kerry Logistics Company Detail
11.15.2 Kerry Logistics Business Overview
11.15.3 Kerry Logistics Biopharmaceutical Cold Chain Transport Introduction
11.15.4 Kerry Logistics Revenue in Biopharmaceutical Cold Chain Transport Business (2019-2024)
11.15.5 Kerry Logistics Recent Development
11.16 SF Express
11.16.1 SF Express Company Detail
11.16.2 SF Express Business Overview
11.16.3 SF Express Biopharmaceutical Cold Chain Transport Introduction
11.16.4 SF Express Revenue in Biopharmaceutical Cold Chain Transport Business (2019-2024)
11.16.5 SF Express Recent Development
11.17 CEVA
11.17.1 CEVA Company Detail
11.17.2 CEVA Business Overview
11.17.3 CEVA Biopharmaceutical Cold Chain Transport Introduction
11.17.4 CEVA Revenue in Biopharmaceutical Cold Chain Transport Business (2019-2024)
11.17.5 CEVA Recent Development
11.18 CH Robinson
11.18.1 CH Robinson Company Detail
11.18.2 CH Robinson Business Overview
11.18.3 CH Robinson Biopharmaceutical Cold Chain Transport Introduction
11.18.4 CH Robinson Revenue in Biopharmaceutical Cold Chain Transport Business (2019-2024)
11.18.5 CH Robinson Recent Development
11.19 Air Canada Cargo
11.19.1 Air Canada Cargo Company Detail
11.19.2 Air Canada Cargo Business Overview
11.19.3 Air Canada Cargo Biopharmaceutical Cold Chain Transport Introduction
11.19.4 Air Canada Cargo Revenue in Biopharmaceutical Cold Chain Transport Business (2019-2024)
11.19.5 Air Canada Cargo Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Deutsche Post DHL
Kuehne + Nagel
FedEx
AmerisourceBergen
UPS (Marken)
DB Schenker
XPO Logistics
Panalpina
Nippon Express
GEODIS
VersaCold
Agility
DSV
Sinotrans
Kerry Logistics
SF Express
CEVA
CH Robinson
Air Canada Cargo

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂